Late diagnosis of Lesch-Nyhan disease variant

BMJ Case Rep. 2013 Dec 10:2013:bcr2013201997. doi: 10.1136/bcr-2013-201997.

Abstract

A 30-year-old man was referred for investigation and management of hyperuricaemia. History included recurrent nephrolithiasis and chronic gout with poor response to medical management. Hypoxanthine-guanine phosphoribosyltransferase (HGPRT) enzyme activity was investigated and found to be deficient confirming the diagnosis of Lesch-Nyhan disease. Hyperuricaemia was treated with allopurinol. To prevent nephrolithiasis, the patient was instructed to avoid dehydration and aim for a minimum urine output of 2 L/day. Urinary alkalinisation with potassium citrate was started. The patient was referred for genetic counselling. This case discusses the genetics, pathophysiology, clinical manifestations, diagnosis and management of HGPRT deficiency.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Allopurinol / therapeutic use
  • Diuretics / therapeutic use
  • Genetic Counseling
  • Gout / etiology
  • Gout Suppressants / therapeutic use
  • Humans
  • Hyperuricemia / diagnosis
  • Hyperuricemia / drug therapy
  • Hyperuricemia / enzymology
  • Hyperuricemia / genetics*
  • Hypoxanthine Phosphoribosyltransferase / deficiency*
  • Hypoxanthine Phosphoribosyltransferase / genetics
  • Lesch-Nyhan Syndrome* / blood
  • Lesch-Nyhan Syndrome* / diagnosis
  • Lesch-Nyhan Syndrome* / drug therapy
  • Lesch-Nyhan Syndrome* / enzymology
  • Male
  • Nephrolithiasis / etiology
  • Nephrolithiasis / prevention & control
  • Potassium Citrate / therapeutic use
  • Uric Acid / blood

Substances

  • Diuretics
  • Gout Suppressants
  • Uric Acid
  • Allopurinol
  • Hypoxanthine Phosphoribosyltransferase
  • Potassium Citrate